SA

Shahbaz Ahmad Siddiqui

Active Director Whole-Time Director DIN 07620219
DIN 07620219 First appointment Oct 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Oct 2016
Shareholding value •••• Premium profile

About Shahbaz Ahmad Siddiqui

Data last updated:

Shahbaz Ahmad Siddiqui is a Whole-Time Director at S.S. Pharma Traders Private Limited (since 2022), Director at East Drug Marchants Private Limited (since 2022) and Director at Vitalwave Laboratories Private Limited (since 2024). The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹147 Cr; the largest is S.S. Pharma Traders Private Limited at ₹130 Cr (FY 2025). Earlier, Shahbaz Ahmad Siddiqui was a Director at Ss Life Science Private Limited (2016–2024).

DIN 07620219
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 13 Oct 2016
Oldest Company Age 4 yrs
Largest company S.S. Pharma Traders Private Limited · ₹130 Cr (FY 2025)
Combined revenue ₹147 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
S.S. Pharma Traders Private Limited U85300UP2022PTC168228
Whole-Time Director25 Jul 20222022₹130 Cr (FY 2025)Active
East Drug Marchants Private Limited U24299WB2022PTC255241
Director01 Jul 20222022₹16.43 Cr (FY 2024)Active
Director31 Aug 20242024₹1.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ss Life Science Private Limited U24299UP2016PTC087046
Director13 Oct 20162016₹65.9 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
East Drug Marchants Private Limited
Vitalwave Laboratories Private Limited
S.S. Pharma Traders Private Limited
Ss Life Science Private Limited
Premium access

Shareholding and investment profile for Shahbaz Ahmad Siddiqui

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shahbaz Ahmad Siddiqui

Shahbaz Ahmad Siddiqui currently holds 3 directorships: S.S. Pharma Traders Private Limited (Whole-Time Director, since 25 Jul 2022, revenue ₹130 Cr (FY 2025)); East Drug Marchants Private Limited (Director, since 01 Jul 2022, revenue ₹16.43 Cr (FY 2024)); Vitalwave Laboratories Private Limited (Director, since 31 Aug 2024, revenue ₹1.9 Lakh (FY 2025)).

Shahbaz Ahmad Siddiqui was first appointed on 13 Oct 2016 as Director at Ss Life Science Private Limited. The most recent appointment on record is 31 Aug 2024 at Vitalwave Laboratories Private Limited.

The 3 current companies of Shahbaz Ahmad Siddiqui that report revenue have a combined latest revenue of ₹147 Cr: S.S. Pharma Traders Private Limited ₹130 Cr (FY 2025); East Drug Marchants Private Limited ₹16.43 Cr (FY 2024); Vitalwave Laboratories Private Limited ₹1.9 Lakh (FY 2025).

Shahbaz Ahmad Siddiqui held 1 earlier board appointment: Ss Life Science Private Limited (Director, 13 Oct 2016 to 20 Aug 2024).

The current boards of Shahbaz Ahmad Siddiqui's companies include Sambit Mohanty (S.S. Pharma Traders Private Limited), Satyendra Tiwari (S.S. Pharma Traders Private Limited), Saima Siddiqui (East Drug Marchants Private Limited), Shadab Ahmad Siddique (East Drug Marchants Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available